Company profile
Aoxing Pharmaceutical Company, Inc.
OTC: AOXG · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Foster City, CIK 0001060426Reports USD
#491 of 1,417 Healthcare companies by revenue70th-percentile growth
EA Score
——FH —DQ 26GM —SS 61
v0.1 · 25/100 weight · pillars only
↑ operating margin, return on assets · ↓ Piotroski F, filing timeliness
Methodology →Revenue TTM
$19.3k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
$2.1M
Employees
346
as of 2026-07-19
Market cap
$266.8k
as of 2026-07-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$32.3M$32.3M2016
Net income$2.1M$2.1M2016
Operating income$6.2M$6.2M2016
Total assets$56.2M$56.2M2016
Equity$19.1M$19.1M2016
Revenue trend
FY2012 – FY2016 · USD
FY12
FY12
FY13
FY14
FY15
FY16
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Aoxing Pharmaceutical Company, Inc.’s revenue?
Aoxing Pharmaceutical Company, Inc. booked $32.3M in FY2016 revenue, growing 27% year over year — faster than most Healthcare companies we track, at a 6.4% net margin.
Peers · Healthcare
C21 Investments Inc.49DGrown Rogue International Inc.52DStereotaxis, Inc.55CMediPharm Labs Corp.61CelectroCore, Inc.57CNova Leap Health Corp.75B+Key facts
CEOZhenjiang Yue
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersFoster City, null
ExchangeOTC: AOXG
Employees346
IPO date2005-02-21
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.